Protease-Activated Receptors (PARs): Biology and Therapeutic Potential in Perioperative Stroke.

IF 3.8 2区 医学 Q1 CLINICAL NEUROLOGY
Translational Stroke Research Pub Date : 2025-06-01 Epub Date: 2024-02-07 DOI:10.1007/s12975-024-01233-0
Theodoros Mavridis, Theodora Choratta, Androniki Papadopoulou, Assaf Sawafta, Paraschos Archontakis-Barakakis, Eleni Laou, Minas Sakellakis, Athanasios Chalkias
{"title":"Protease-Activated Receptors (PARs): Biology and Therapeutic Potential in Perioperative Stroke.","authors":"Theodoros Mavridis, Theodora Choratta, Androniki Papadopoulou, Assaf Sawafta, Paraschos Archontakis-Barakakis, Eleni Laou, Minas Sakellakis, Athanasios Chalkias","doi":"10.1007/s12975-024-01233-0","DOIUrl":null,"url":null,"abstract":"<p><p>Perioperative stroke is a devastating complication that occurs during surgery or within 30 days following the surgical procedure. Its prevalence ranges from 0.08 to 10% although it is most likely an underestimation, as sedatives and narcotics can substantially mask symptomatology and clinical presentation. Understanding the underlying pathophysiology and identifying potential therapeutic targets are of paramount importance. Protease-activated receptors (PARs), a unique family of G-protein-coupled receptors, are widely expressed throughout the human body and play essential roles in various physiological and pathological processes. This review elucidates the biology and significance of PARs, outlining their diverse functions in health and disease, and their intricate involvement in cerebrovascular (patho)physiology and neuroprotection. PARs exhibit a dual role in cerebral ischemia, which underscores their potential as therapeutic targets to mitigate the devastating effects of stroke in surgical patients.</p>","PeriodicalId":23237,"journal":{"name":"Translational Stroke Research","volume":" ","pages":"933-951"},"PeriodicalIF":3.8000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Stroke Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12975-024-01233-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Perioperative stroke is a devastating complication that occurs during surgery or within 30 days following the surgical procedure. Its prevalence ranges from 0.08 to 10% although it is most likely an underestimation, as sedatives and narcotics can substantially mask symptomatology and clinical presentation. Understanding the underlying pathophysiology and identifying potential therapeutic targets are of paramount importance. Protease-activated receptors (PARs), a unique family of G-protein-coupled receptors, are widely expressed throughout the human body and play essential roles in various physiological and pathological processes. This review elucidates the biology and significance of PARs, outlining their diverse functions in health and disease, and their intricate involvement in cerebrovascular (patho)physiology and neuroprotection. PARs exhibit a dual role in cerebral ischemia, which underscores their potential as therapeutic targets to mitigate the devastating effects of stroke in surgical patients.

Abstract Image

蛋白酶激活受体(PARs):围手术期中风的生物学和治疗潜力。
围手术期中风是一种破坏性并发症,发生在手术过程中或手术后 30 天内。其发病率从 0.08% 到 10% 不等,但很可能被低估,因为镇静剂和麻醉剂会严重掩盖症状和临床表现。了解潜在的病理生理学并确定潜在的治疗目标至关重要。蛋白酶激活受体(PAR)是一个独特的 G 蛋白偶联受体家族,在人体内广泛表达,在各种生理和病理过程中发挥着重要作用。这篇综述阐明了 PARs 的生物学特性和意义,概述了它们在健康和疾病中的各种功能,以及它们在脑血管(病理)生理学和神经保护中的复杂参与。PARs 在脑缺血中表现出双重作用,这凸显了它们作为治疗靶点的潜力,可减轻中风对手术患者的破坏性影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Translational Stroke Research
Translational Stroke Research CLINICAL NEUROLOGY-NEUROSCIENCES
CiteScore
13.80
自引率
4.30%
发文量
130
审稿时长
6-12 weeks
期刊介绍: Translational Stroke Research covers basic, translational, and clinical studies. The Journal emphasizes novel approaches to help both to understand clinical phenomenon through basic science tools, and to translate basic science discoveries into the development of new strategies for the prevention, assessment, treatment, and enhancement of central nervous system repair after stroke and other forms of neurotrauma. Translational Stroke Research focuses on translational research and is relevant to both basic scientists and physicians, including but not restricted to neuroscientists, vascular biologists, neurologists, neuroimagers, and neurosurgeons.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信